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Abstract: The utilization and demand of self-medication with herbomineral-based formulations have increased day-by-day 
across the globe over the last decade. A new proprietary herbomineral formulation was prepared with the mixture of minerals 
(zinc, magnesium, and selenium) and the herbal root extract of ashwagandha. The current study was undertaken to evaluate the 
Biofield Energy Healing (The Trivedi Effect
®
) on the test herbomineral formulation using murine dendritic cells (DCs) and 
splenocytes in vitro. The formulation was divided into two parts, one part was control without any Biofield Energy Treatment, 
while the other part was defined as the Biofield Energy Treated sample, which received the Biofield Energy Healing Treatment 
remotely from eighteen renowned Biofield Energy Healers. The effect of the Biofield Energy Treated formulation in murine 
cells was monitored with an estimation of pro-inflammatory cytokines levels such as tumor necrosis factor (TNF-α), 
macrophage inflammatory protein-1α (MIP-1α) and interleukin (IL-1β) in cell culture supernatants along with estimations of 
non-cytotoxic concentrations of the test formulation by MTT assay. The Biofield Treated formulation showed 114.2%, 
122.6%, 141.2%, 127.8%, and 114.1% cell viability at concentrations 1.05, 5.2, 10.5, 25.6, and 51.2 µg/mL, respectively in 
DCs. Similarly, the Biofield Energy Treated and untreated formulations showed more than 100% cell viability in mice 
splenocytes at 5 µg/mL. The level of TNF-α in DCs was significantly (p≤0.05) inhibited by 19.21% in the Biofield Treated 
formulation at concentration 5.2 µg/mL as compared to the untreated test formulation. The level of MIP-1α in LPS induced 
mice splenocyte cells was reduced by 15.35% in the Biofield Energy Treated formulation at 0.0105 µg/mL as compared to the 
untreated formulation. Similarly, the level of IL-1β in LPS induced mice splenocyte cells was significantly (p≤0.05) reduced 
by 31.59% in the Biofield Treated formulation at 1.05 µg/mL as compared to the untreated formulation. Altogether, the results 
suggest that The Trivedi Effect
®
 (Biofield Energy Healing Treatment) showed significant down-regulation of the tested pro-
inflammatory cytokines expression and potentiated the immunosuppressive effect of the treated formulation to modulate the 
immune system. These data also suggest that the Biofield Treated test formulation can be used for autoimmune and 
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inflammatory diseases, stress management and anti-aging by improving overall health. 
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1. Introduction 
Since ancient times, natural products have played primary 
roles in Complementary and Alternative Medicine (CAM) 
and have been used worldwide for the treatment and 
prevention of various diseases or ailments. Moreover, the use 
of alternative and complementary medicine has increased in 
circumstances where conventional medicine and the 
allopathic model of health care is ineffective, i.e. cases of 
advanced diseases like cancer or with ailments/problems that 
are not limited to only the brain and the body. Many 
medicinal plants and minerals have immunomodulatory 
properties. The ashwagandha (Withania somnifera) plant is 
one important herbal product that is widely used in 
complementary and alternative medicine for various types of 
diseases. There has been increased interest in the use of 
natural substances, especially pertaining to plants, derived 
herbal extracts and various essential minerals, which are 
collectively known as nutraceuticals [1]. The herbal extracts 
report various pharmacological benefits such as 
immunostimulation, stress reduction, appetite stimulation, 
growth promotion and antimicrobial properties. These effects 
were found to be caused by the presence of active 
constituents such as steroids, flavonoids pigments, alkaloids, 
phenolics, and terpenoids [2]. Based on the literature, a new 
proprietary herbomineral formulation was prepared that 
combined the herbal root extract of ashwagandha with three 
minerals viz. zinc, magnesium, and selenium. Ashwagandha 
root is a traditional Indian herb (also known as Indian 
Ginseng) commonly used as a constituent in herbal tonic 
preparation. It is considered an 'adaptogen', (a term used to 
describe herbs that improve physical energy, athletic ability 
and vitality, as well as increase sexual capacity, fertility and 
immunity to cold infections) [3]. Herbal preparations that 
contain ashwagandha root extract have shown anti-
inflammatory, anti-arthritic, antibiotic, anti-tumor, and 
immunomodulatory effects with withanolides [4, 5]. 
Ashwagandha root extract has been shown to modulate the 
immune response via cytokines expression level [6]. 
Mazumder et al. (2012) reported that zinc, along with 
Glycyrrhiza glabra, had increased the leukocyte count and 
phagocytic index and potentiated immunomodulatory effects 
[7]. Sodium selenate greatly improved the process of 
lymphocytes proliferation to the increased level of IL-2. The 
literature reports that sodium selenate increased the 
phagocytic index and down-regulated the expression levels 
of pro-inflammatory cytokines viz. IL-1, IL-6, and TNF-α 
[8]. Selenium produces antioxidant properties by scavenging 
free-radicals. Selenium also plays an important role in 
several immunological and metabolic processes of 
phagocyted bacteria during intracellular digestion [9]. Many 
trace elements such as zinc, magnesium, selenium, copper 
and manganese etc. have strong immunomodulatory effects 
[10]. Different cytokines are involved in host responses with 
respect to the inflammation and immune activation process 
that lead to various diseases [11]. Therefore, anti-
inflammatory phytomedicines are used as an adjunct therapy 
for the management of chronic inflammatory disorders [12-
14]. 
Dendritic cells (DCs) play an important role in the immune 
system and possess the ability to stimulate naive T cells. 
Murine DCs are characterized by CD11c marker expression, 
which is a common marker among plasmacytoid and myeloid 
DCs [15]. Thymus derived lymphocyte helper cells 1 (TH1) 
are the primary sources for interleukin-1β (IL-1β), tumor 
necrosis factor-α (TNF-α), IL-2, interferon-ϒ (IFN-ϒ), 
lymphotoxins and other factors which characterize the cell-
mediated immune responses [16]. The different types of 
immune cells such as DCs, macrophages and spleen play an 
important role in stopping acute/chronic inflammation and 
retrieving a steady state strategy through the secretion of 
immuno-modulating cytokines [17]. These immune cells 
have been reported to be useful as cellular models for in vitro 
studies. Therefore, murine bone marrow derived dendritic 
cells (BMDCs) and splenocytes were used to assess the effect 
of the test formulation on in vitro cell cultures. In recent 
years, Biofield Energy Healing Treatment has been accepted 
as an alternative and complementary method of health care 
and has been shown to have impacts on various properties of 
living organisms in a cost-effective manner [18]. The use of 
alternative and integrative medicine approaches have 
increased in the facilitation of wellness and because of their 
minimal side-effects for cancer patients and people suffering 
from chronic diseases. Recent studies report that the uses of 
energy medicine provide the highest benefit to cancer 
patients as compared to other complementary and alternative 
forms of medicine [19]. 
Human Biofield Energy has subtle energy that has the 
capacity to work in an effective manner [20]. Reports show 
that CAM therapies have been practiced worldwide with 
reports of clinical benefits in different health disease profiles 
[21]. Biofield Energy comes under the category of energy 
medicine, which is well defined and accepted by National 
Center for Complementary and Integrative Health (NCCIH), 
a subdivision of the National Institutes of Health (NIH). This 
energy can be harnessed and transmitted by individuals into 
living and non-living things via the process of Biofield 
Energy Healing. Biofield Energy Healing Treatment (The 
Trivedi Effect
®
) have been known to transform the structural, 
physical, and thermal properties of various metals, chemicals, 
ceramics and polymers in materials science [22-25], 
improved the overall productivity, yield and quality of crops 
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[26-29], altered characteristics and features of microbes [30-
33], improved excellent outcomes of various nutraceutical 
compounds in the fields of nutraceuticals [34-37], and 
improved the growth and anatomical characteristics of 
various medicinal plants [38, 39]. Based on the literature 
related to Biofield Energy Treatment, the authors of this 
study sought to investigate the effects of Biofield Energy 
(The Trivedi Effect
®
) on the test herbomineral formulation, 
which might modulate the key pro-inflammatory cytokines 
expression in in vitro murine DCs and splenocytes models. 
2. Materials and Methods 
2.1. Chemicals and Reagents 
3-(4, 5-diamethyl-2-thiazolyl) 2, 5 diphenyl-2H-
tetrazolium) (MTT), Lipopolysaccharide (LPS), L-glutamine, 
RPMI-1640, penicillin, HEPES, streptomycin, 2- 
mercaptoethanol were purchased from Sigma Chemical 
Company in St. Louis, MO, a subsidiary of Sigma-Aldrich 
Corporation. ELISA (enzyme-link immunosorbent assay) 
assay kits for all cytokines such as TNF-α, macrophage 
inflammatory protein-1α (MIP-1α), and IL-1β were 
purchased from R&D systems, U.S.A. Fetal bovine serum 
(FBS) was procured from GIBCO, U.S.A. Ashwagandha root 
extract powder was procured from Sanat Products Ltd., India. 
Zinc chloride and magnesium (II) gluconate hydrate were 
procured from Tokyo Chemical Industry Co., Ltd. (TCI, 
Japan). Sodium selenate was procured from Alfa Aesar, 
U.S.A. Rapamycin, NaHCO3, and EDTA were procured from 
Sigma. All other chemicals used in this experiment were of 
analytical grade and procured from local vendors. 
2.2. Test Formulation and Reference Standard 
The test formulation contained the combination of four 
ingredients: zinc chloride, magnesium gluconate, sodium 
selenate, and ashwagandha root powder extract. Different 
concentrations of the test formulation were used for the study 
i.e. concentration range of 1.05 to 1052.5 µg/mL for bone 
marrow DCs and 0.0000105 to 10.5 µg/mL with LPS 
stimulated splenocyte culture for cell viability assay. LPS 
was used as an immunostimulant and as an inducing agent at 
0.5 µg/mL and rapamycin (1 and 10 nM) was used as the 
reference standard (positive control) in splenocyte culture. 
TNF-α estimated in DCs, which was treated with 0.1% 
DMSO, served as the vehicle control group. MIP-1α and IL-
1β were estimated in splenocyte cells, which includes 
splenocyte cells treated with LPS (0.5 µg/mL) along with 
0.005% DMSO, and was defined as the vehicle control 
group. 
2.3. Biofield Energy Treatment Strategies 
The herbomineral formulation was divided into two parts. 
One part was considered the control sample and the other 
part was defined as the treated sample. Both samples were 
kept under standard laboratory conditions at the research 
laboratory Dabur Research Foundation near New Delhi in 
Ghaziabad, India. The treated sample was subjected to 
Biofield Energy Healing (also known as The Trivedi 
Effect
®
), which was remotely administered for a period of 5 
minutes by a group of eighteen Biofield Energy Healers, 
eleven of which were remotely located in the U.S.A., four in 
Canada, one in the UK, one in Russia and one in Ireland. 
Similarly, the control sample was subjected to “sham” 
healers under the same laboratory conditions for 5 minutes. 
The sham healers did not have any knowledge about the 
Biofield Energy Treatment. After that, the Biofield Energy 
Treated and untreated samples were kept in similar sealed 
conditions and used for the in vitro study on DCs and 
splenocytes for cytokines estimation. 
2.4. Experimental Animal 
C57BL/6 male mice (8 weeks old) were purchased from 
M/S Vivo Bio Tech Ltd., Hyderabad, India and acclimatized 
for one week prior to the experiment. The mice were 
maintained under controlled conditions with a temperature of 
22 ± 3°C, humidity of 30–70% and a 12-hour light/12-hour 
dark cycle and rodent laboratory diet and drinking tap water 
were provided ad libitum. All the procedures were followed 
in strict accordance with the Guide for the Care and Use of 
Laboratory Animals published by the US National Institutes 
of Health. Approval was obtained from the Institutional 
Animal Ethics Committee prior to carrying out the animal 
experiments. The various concentrations of the test 
formulation were used from 1.05 to 51.2 µg/mL for BMDCs 
and 0.0000105 to 1.05 µg/mL for LPS stimulated splenocytes 
culture. The respective vehicle controls (DMSO) were kept 
in the assay. 
2.5. Mouse Bone Marrow-Derived Dendritic Cells (DCs) 
Cultures 
C57BL/6 male mice were euthanized by CO2 asphyxiation. 
Subsequent experimental steps were conducted in a laminar 
air flow. BMDCs were induced from bone marrow (BM) 
cells using the modified method of Inaba et al. (1992) [40]. 
Briefly, a single cell suspension was prepared from BM 
obtained from the femur. After removing all muscle tissues 
from the femur using gauze, the bones were placed in a 90 
mm dish with 70% alcohol for 1 minute, washed twice with 
PBS, and then transferred into a fresh dish containing RPMI 
1640 medium. Both ends of the bones were cut with scissors 
in the dish, and then the bone marrow (BM) was flushed out 
using 2 mL of RPMI 1640 medium with the help of a syringe 
attached with a 25-gauge needle. To remove small pieces of 
bone and debris, the tissue was suspended and passed 
through a nylon mesh and red blood cells were lysed with 
ammonium chloride. After washing, lymphocytes and other 
cells were killed with a cocktail of monoclonal antibodies 
(mAbs) and rabbit complement for 60 minutes at 37°C. After 
that, whole BM cells (2 × 10
6
 cells/mL) were cultured in 
RPMI 1640 medium in 90 mm Petri dishes (Sigma Aldrich, 
St. Louis, MO) at 37°C, 5% CO2, supplemented with 10% 
FBS, 2 mM L-glutamine, 100 U/mL penicillin G, 100 mg/mL 
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streptomycin, 20 ng/mL recombinant mouse GM-CSF (R & 
D systems Inc., U.S.A.). The cells were incubated for 24 
hours. The petri-plates were then gently swirled and the 
medium containing non-adherent cells, and which was then 
removed and replaced with the nutrient medium as described 
above. The supplemented medium was replaced every three 
days. On day 6, non-adherent and loosely adherent DCs were 
collected, washed, and seeded in culture plates for further 
assays. Cell counts were performed using a hemocytometer 
and cell viability was determined with the help of trypan-blue 
dye exclusion technique, results showing ≥95% of viable 
cells. The cells were cultured in 96-well tissue culture plates 
with 5 x 10
3
 cells per well. They were incubated at 37°C in a 
humidified atmosphere with 5% CO2 for the indicated period. 
2.6. Mouse Splenocyte Cultures 
C57BL/6 male mice were sacrificed and the spleens were 
removed and ground by passing them through a sterile plastic 
strainer under aseptic conditions. After that, the cells were 
centrifuged twice at 1000 g for 5 minutes. Erythrocytes were 
lysed by lysis buffer (0.15 M NH4Cl, 0.01 M NaHCO3, and 
0.1 mM EDTA, pH 7.4) and then the cell pellets were washed 
twice with RPMI-1640 medium. Then, the cells were 
resuspended in a complete RPMI-1640 medium (RPMI 1640 
medium plus 10% FBS, 2 mM glutamine, streptomycin and 
100 IU/mL of penicillin and 15 mM HEPES, and 50 mM 2-
mercaptoethanol). Cell counts were performed with the help 
of hemocytometer and cell viability was determined using 
trypan-blue dye exclusion technique, the results showing 
≥95% of viable cells. The cells were cultured in 96-well 
tissue culture plates with 0.2 x 10
6
 cells per well. They were 
incubated at 37°C in a humidified atmosphere containing 5% 
CO2 for the specified period. 
2.7. Cytotoxicity by MTT Assay 
The number of viable cells was estimated based on the 
conversion of MTT to formazan dye using mitochondrial 
enzyme. Both cells were cultured overnight in 96-well plates, 
at a density of 5 x 10
3
 cells per well for BMDCs and 0.2 x 
10
6
 cells per well for splenocytes. After the Biofield Energy 
Treatment on the test formulation with the desired incubation 
period, the medium was removed. 20 µL of 5 mg/mL MTT 
was then added to each well and incubated for 3 hours further 
at 37
o
C in a humidified 5% CO2 atmosphere. The cells were 
centrifuged and supernatants were removed. The cell pellet in 
each well was resuspended in 150 µL of DMSO to dissolve 
formazan crystals. The optical density of each well was read 
at 540 nm using Biotek Reader (SIAFRT/Synergy HT 
multimode reader). The effect of the test formulation on cell 
viability of DCs and splenocyte cells was determined as per 
equation 1: 
%	Cell	viability = 100 −%	Cytotoxicity           (1) 
Where; % Cytotoxicity = {(O.D. of Control cells – O.D. of 
cells treated with the test formulation)/ OD of Control 
cells}*100. 
The concentrations that resulted in >95% viability were 
selected for subsequent cytokine estimation. 
2.8. Cytokines Assays Using ELISA 
The effects of the Biofield Energy Treated and untreated 
test samples on the production of TNF-α, MIP-1α and IL-1β 
were measured by ELISA method using culture supernatants 
collected from the treated cells. Briefly, ELISA plates were 
coated overnight and kept at 4
◦
C with coating buffer 
containing capture antibody at the recommended 
concentration. After washing with PBS-T (PBS with 0.05% 
Tween 20), the plates were blocked with assay diluent for at 
least 2 hours at room temperature. 100 µL of culture 
supernatants from different experimental samples and 
standards were incubated overnight at 4
◦
C and, after three 
washes, biotinylated anti-mouse cytokine (TNF-α, MIP-1α 
and IL-1β) antibodies at the recommended concentrations 
were incubated for 1 hour at room temperature and the plate 
was incubated for 45 minutes at room temperature with 
gentle shaking. Plates were again washed 3 times and then 
100 µL of horseradish per-oxidase (HRP)-streptavidin 
conjugate solution was added and the plate was incubated for 
45 minutes at room temperature with gentle shaking in a 
shaker. Next, the plate wells were washed 3 times and 100 
µL of 3,3,5,5'-tetramethylbenzidine (TMB) was added to the 
wells, followed by 30 minutes of incubation at room 
temperature in the dark. Then 50 µL of 0.2 mol/L sulphuric 
acid was added to each well to stop the reaction. After that, 
the plates were read for absorbance at 450 nm using a Biotek 
reader (SIAFRT/Synergy HT multimode reader). Standards 
were run in parallel to the samples. Concentrations were 
determined and the experiment was done in triplicates. 
2.9. TNF-α Level in Mouse Dendritic Cells (DCs) 
DCs were seeded in a 24-well plate at a density of 0.5 x 
10
6
 cells per well with 1 mL of culture medium and co-
incubated for 24 hours with different non-cytotoxic 
concentrations ranging from 25 to 500 µg/mL of the Biofield 
Treated and untreated test samples. DCs treated with 0.1% 
DMSO was included as the vehicle control. After 24 hours of 
incubation, culture supernatants were collected and assayed. 
The supernatants were analyzed for the estimation of TNF-α 
using ELISA as per the manufacturer’s instructions [41]. 
Concentrations were determined in two wells in each sample 
and this experiment was conducted in triplicates. 
2.10. MIP-1α and IL-1β in Splenocytes 
For estimation of MIP-1α and IL-1β in LPS (0.5 µg/mL) 
induced splenocytes (2 x 10
6
 cells/well in 24-well culture 
plates) were treated with the Biofield Treated and untreated 
test formulations at selected non-toxic concentrations 
(0.00005 to 5 µg/mL) in triplicates. Splenocytes treated with 
LPS along with 0.005% DMSOs were included as control 
cells. Untreated cells were included as a negative control. 
Rapamycin was included as a positive control. After 48 hours 
of incubation, the supernatants were analyzed for the secreted 
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levels of MIP-1α and IL-1β using ELISA as per the 
manufacturer’s instructions [42, 43]. 
2.11. Statistical Analysis 
The experiment was performed in triplicates and the data 
are presented as mean ± standard error of mean (S.E.M.). 
Comparisons of the means of control and test groups were 
subjected to Student’s t-test for two group comparison. 
Statistical significance was considered at p≤0.05. 
3. Results 
3.1. In Vitro Immune Cells Viability Assay by MTT Assay 
The effects of the Biofield Energy Treated and untreated 
test formulations on the proliferation of mouse BMDCs and 
splenocyte cells were examined after 24 hours and 48 hours, 
respectively using MTT cell viability assay. The effects of 
the test formulation on the viability of DCs and splenocytes 
are shown in Figure 1 and Figure 2, respectively. The cell 
viability in the untreated test group showed 136.30%, 
141.90%, and 113.00% at concentrations of 5.2, 25.6, and 
51.2 µg/mL, respectively in DCs. Further, increasing the 
dose of the untreated sample resulted in reduced cell viability 
up to 26% at 210.5 µg/mL. So, the dose ranges from 1.05 to 
51.2 µg/mL were selected for the cytokine (TNF-α) 
estimation. Similarly, the Biofield Energy Treated 
formulation showed 114.2%, 122.6%, 141.2%, 127.8%, and 
114.1% cell viability at concentrations of 1.05, 5.2, 10.5, 
25.6, and 51.2 µg/mL, respectively in DCs. The increased 
cell viability with respect to the vehicle control might be due 
to proliferation in the cell culture. Further, increasing the 
dose of the Biofield Treated formulation resulted in 
decreased cell viability up to 25% at concentration 210.5 
µg/mL. 
 
Figure 1. MTT Assay in mouse bone marrow dendritic cells (DCs) after 24 hours of treatment with various concentrations of the test formulation in the 
absence of LPS. The absorbance of the MTT formazan was determined at 540 nm in an ELISA reader. Cell viability was defined as the absorbance ratio 
(expressed as a percentage) of the Biofield Energy Treated cells relative to the untreated vehicle cells. 
LPS induced splenocytes were treated with the test 
formulation at the concentration ranges from 0.0000105 to 
1.05 µg/mL for 48 hours. The result of percent cell viability 
is presented in Figure 2. The cytokines analysis was also 
conducted using the same concentration range. The cell 
viability of the LPS group was 122.8%, while rapamycin (the 
reference standard of the immunosuppressive agent) showed 
74.2% and 81.6% cell viability at 1 and 10 nM, respectively. 
Both the Biofield Energy Treated and untreated test 
formulations showed more than 100% cell viability at 5 
µg/mL concentration. Therefore, the dose range from 
0.0000105 to 1.05 µg/mL of the test formulation was selected 
for the cytokines (MIP-1α and IL-1β) estimation. 
 
Figure 2. MTT Assay in splenocyte cells after 48 hours of treatment with various concentrations of the test sample in the presence of 0.5 µg/mL of LPS. The 
absorbance of the MTT formazan was determined at 540 nm in an ELISA reader. Cell viability was defined as the absorbance ratio (expressed as a 
percentage) of the Biofield Treated cells relative to the untreated vehicle cells. 
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3.2. Effect of the Test Formulation on the Expression of 
Pro-inflammatory Cytokines TNF- α, MIP-1α and  
IL-1β in Immune Cells 
Lymphocyte proliferation and the activation of natural 
killer (NK) cells are cytokine dependent [44]. The type of 
cytokine up/down regulation affects the course of immune 
response and the whole network of immune regulation. The 
pro-inflammatory cytokines TNF- α, MIP-1α and IL-1β play 
a pivotal role in inflammation, immune modulation, and 
lymphocyte activation. Various herbomineral formulations 
have the potential to modulate the expression and activation 
of cytokines. Therefore, we examined the effect of the test 
formulation on the levels of TNF-α, MIP-1α and IL-1β 
expression at two different immune cells: dendritic and 
spleen cells. The production of the cytokines by these 
immune cells was tested in the culture supernatants using the 
commercial ELISA kits. 
3.3. Modulation of TNF-α Expression in Mouse Bone 
Marrow Dendritic Cells (BMDCs) 
DCs were treated with the test formulation at non-cytotoxic 
concentrations for 24 hours. The effect of the formulation on 
TNF-α secretion in DCs is represented in Figure 3. Both the 
untreated and Biofield Energy Treated test formulation groups 
demonstrated decreased levels of TNF-α secretion at different 
concentrations i.e. 1.05, 5.2, 10.5, 25.6, and 51.2 µg/mL as 
compared to the vehicle control group. The maximum down-
regulation effect was observed at 25.6 µg/mL of the Biofield 
Treated and untreated formulations with respect to the vehicle 
control group. The Biofield Energy Treated and untreated 
formulations showed 59.3 and 73.4 pg/mL of TNF-α levels at 
5.2 µg/mL as compared to the control group. Therefore, the 
level of TNF-α in the Biofield Treated group was decreased by 
19.21% as compared to the untreated group, which was 
statistically significant (p≤0.05) (Figure 3). 
 
Figure 3. Dose-dependent inhibition of TNF-α by the test formulation. For each concentration treatment, the level of TNF-α release was measured after 24 
hours of treatment. The values are represent as means ± SEM of independent ELISA experiment, *p≤0.05 as compared to the untreated test formulation. 
3.4. Modulation of MIP-1α and IL-1β Expression in Mouse 
Splenocytes 
Splenocytes were cultured in RPMI-FBS (10%) with LPS 
and the levels of MIP-1α and IL-1β cytokines were measured 
by ELISA in the culture supernatants. The effect of the test 
formulation on each cytokine production was observed after 
48 hours of incubation at various concentrations of the 
Biofield Energy Treated and untreated test formulations. 
Rapamycin was used as the positive control. 
 
Figure 4. Dose-dependent inhibition of LPS mediated production of MIP-1α by test formulation. For each concentration treatment, the level of MIP-1α release 
was measured after 48 hours of treatment. The values are represented as mean ± SEM of independent ELISA experiments. 
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3.4.1. MIP-1α Expression 
The effect of the test formulation on MIP-1α secretion in 
splenocytes is shown in Figure 4. This figure demonstrates 
the comparative expression profile of MIP-1α secretion in 
splenocytes of the Biofield Treated and untreated groups. 
Both the untreated and Biofield Treated formulations 
demonstrated inhibition of MIP-1α expression as compared 
to the LPS stimulated cells (vehicle control). However, the 
Biofield Energy Treated formulation group enhanced the 
down-regulation of MIP-1α. At concentration 0.105 µg/mL, 
the level of MIP-1α was observed as 1915.5 and 2144.1 
pg/mL in the Biofield Treated and untreated formulation 
groups, respectively. Moreover, there was 10.66% reduction 
of MIP-1α in the Biofield Treated group as compared to the 
untreated group. The level of MIP-1α was observed as 
2087.8 pg/mL and 2466.4 pg/mL in the Biofield Treated and 
untreated test formulation groups, respectively at 0.0105 
µg/mL. There was 15.35% reduction of MIP-1α in the 
Biofield Treated group as compared to the untreated group. 
3.4.2. IL-1β Expression 
Figure 5 demonstrates the comparative effect of the Biofield 
Energy Treated and untreated formulation on IL-1β secretion 
in splenocytes. Both the untreated and the Biofield Treated 
test formulations demonstrated inhibition of IL-1β as 
compared to the LPS stimulated cells (vehicle control). The 
Biofield Energy Treated formulation exhibited better 
inhibition of IL-1β secretion than the untreated formulation 
group at most of the tested concentrations. The level of IL-1β 
was observed as 329.5 pg/mL and 349.9 pg/mL in the 
Biofield Treated and untreated groups, respectively at 
0.00105 µg/mL. There was 5.83% reduction of IL-1β in the 
Biofield Treated group as compared to the untreated group. 
Moreover, at concentration 0.0105 µg/mL, the level of IL-1β 
was observed as 332.3 pg/mL in the case of the Biofield 
Energy Treated group, whereas 378.4 pg/mL was found in 
the untreated group. There was 12.18% reduction of IL-1β in 
the Biofield Treated group as compared to the untreated 
group. Additionally, at concentration 0.105 µg/mL, level of 
IL-1β was unchanged between the Biofield Treated and 
untreated test formulation groups. However, at concentration 
1.05 µg/mL the level of IL-1β was found at 272.4 pg/mL and 
398.2 pg/mL in the Biofield Treated and untreated group, 
respectively. There was statistically significant (p≤0.05) 
reduction of IL-1β by 31.59% in the Biofield Treated group 
as compared to the untreated group. 
 
Figure 5. Dose-dependent inhibition of LPS mediated production of IL-1β by test formulation. For each concentration treatment, the level of IL-1β release was 
measured after 48 hours of treatment. The values are represented as mean ± SEM of independent ELISA experiment, *p≤0.05 as compared to the untreated test 
formulation. 
4. Discussion 
The use of herbomineral products to maintain or improve 
overall health has gradually increased across the globe over the 
last couple of years. Herbal extracts have also been shown to 
modulate immune responses during inflammation. A new 
proprietary herbomineral formulation was developed, 
consisting of four ingredients viz. ashwagandha, zinc, 
magnesium and selenium. Ashwagandha was shown to inhibit 
TNF-α induced NF-κB activation in human myelomonoblastic 
leukemia cells in a study conducted by Singh and Aggrawal 
(1995) [45, 46]. Zinc deficiency influences the generation of 
cytokines, including IL-1β, IL-2, IL-6, and TNF-α, and in 
response to zinc supplementation, plasma cytokines exhibit a 
dose-dependent response. The mechanism of action may 
reflect the ability of zinc to either induce or inhibit the 
activation of NF-κB. The major involvement of zinc in the 
immune system [47] includes an ability to influence the 
production and signaling of numerous inflammatory cytokines 
in a variety of cell types [48, 49]. Magnesium sulphate reduced 
cytokine production in intrapartum women and term and 
preterm neonates, demonstrating effectiveness in those at risk 
for inflammation associated with adverse perinatal outcomes, 
whereby magnesium plays a critical regulatory role in NF-κB 
activation, cytokine production, and disease pathogenesis [50]. 
Recently, Chen Y. et al. (2009), reported that the 
supplementation of MC3T3-E1 with methylseleninic acid 
(MSA) (0.5 mM to 4 mM) reduced the activation of NF-kB 
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leading to a decrease in IL-6, MCP-1, COX-2 and iNOS in 
response to MDA-MB-231 conditioned medium [51]. The 
authors of this study developed a product which showed 
immunostimulating effects that could contribute to the 
maintenance of the immune system, which may prevent the 
progression of acute or chronic diseases. Inflammation is the 
first response of the immune system to infection or irritation. 
It is caused by cytokines such as TNF-α, IL-1 and IL-6, and 
by eicosanoid such as PGE2. Thus, inhibitors of these 
cytokines have been considered as a candidate for anti-
inflammatory drugs. The immune cells, especially the bone 
marrow cells such as dendritic and splenocyte cells, are 
always used to screen the potential immunomodulatory effect 
of a substance/product. This is because the thymus is the 
major primary lymphoid organ for T cell development, while 
bone marrow is for B and NK cells. These immune cells then 
migrate to the spleen, which is the secondary lymphoid 
tissue, and respond to antigens in there. Therefore, the 
regulation of thymus and spleen cell proliferation, which is 
closely related to maintaining immune homeostasis, can be 
considered as an important marker for immune response 
control. Lymphocytes/monocytes/macrophages are key 
mediators of inflammation and are widely distributed in the 
body. Therefore, mouse bone marrow derived DCs and 
splenocytes, which represent appropriate model systems to 
study the immune responses, were utilized to investigate the 
anti-inflammatory effects of the newly developed proprietary 
herbomineral formulation. 
Based on the literature, it has been shown that human 
emotions such as loneliness are directly correlated with the 
down-regulation of genes bearing anti-inflammatory 
response elements and the up-regulation of genes bearing 
response elements for pro-inflammatory NF-kappaB/Rel 
transcription factors [52]. In this study, the cytotoxic effect of 
the Biofield Energy Treated formulation was screened by 
assessing the metabolic activity of immune cells through 
MTT assay. MTT assay was previously proven to show the 
similar result in cell proliferation as the bromodeoxyuridine 
(BrdU) assay, because its accurate correlation between the 
metabolic activity and cell growth was proven [53]. The anti-
inflammatory effects of both the Biofield Energy Treated and 
untreated test samples were evaluated here in two different 
immune cells from the mice. The metabolic activity is 
evaluated by measuring the activity of a mitochondrial 
enzyme succinate dehydrogenase using the MTT test. This 
test is widely used in the in vitro evaluation of the toxicity of 
any test item. Both DCs and splenocytes (immune cells) were 
exposed to various concentrations (1.05 to 51.2 µg/mL for 
DCs and 0.0000105 to 1.05 µg/mL for splenocytes) of the 
test formulation for 24 hours and 48 hours, respectively. 
There was a significant reduction in the DCs viability at 
concentration >51.2 µg/mL and splenocyte cells showed 
cytotoxic at 10.5 µg/mL of the test formulation. 
The Biofield Treated test formulation demonstrated the 
greatest potential for modulating the inflammatory response of 
DC and splenocyte cells in vitro assay. There was a significant 
reduction of TNF-α, MIP-1α and IL-1β levels in the 
supernatants of all tested concentrations. Importantly, these 
effects were not attributed to a decrease in cellular viability, 
indicating that this formulation was not adversely affecting these 
cultured murine DCs and splenocytes. It is worthwhile to note 
that the anti-inflammatory effects of the test formulation were 
observed in both DCs and mouse splenocytes with the 
suppression of pro-inflammatory cytokines (TNF-α, MIP-1α and 
IL-1β) production. Several cytokines are deeply associated with 
most inflammatory diseases. In particular, TNF-α and IL-1β are 
prominent contributors to chronic inflammatory disorders. Our 
data suggests that the test formulation modulates DC and 
splenocytes function. The Biofield Energy Treated formulation 
showed significant inhibition of pro-inflammatory cytokines 
expression like TNF-α, MIP-1α and IL-1β as compared to the 
untreated formulation. Therefore, The Trivedi Effect
®
 may act 
via the specific inhibition of nuclear factor-kappa B (NF-κB), a 
transcription factor involved in the activation of many 
inflammatory mediator genes. 
5. Conclusions 
Overall, results suggest that the Biofield Energy Treated 
formulation exerts better and significant inhibition of pro-
inflammatory cytokines (TNF-α, MIP-1α and IL-1β) 
expression levels as compared to the untreated group in both 
immune cells viz. of DCs and splenocytes. The level of TNF-α 
was significantly suppressed (p≤0.01) by 19.21% in DCs in the 
Biofield Treated test group at 5.2 µg/mL as compared to the 
untreated test formulation group. The level of MIP-1α in LPS 
induced splenocyte cells was reduced by 15.35% in the 
Biofield Energy Treated test formulation at 0.0105 µg/mL as 
compared to the untreated test formulation group. Moreover, 
the level of IL-1β in LPS induced splenocyte cells was 
significantly (p≤0.05) reduced by 31.59% in the Biofield 
Treated test group at the concentration of 1.05 µg/mL as 
compared to the untreated group. In conclusion, the Biofield 
Energy Treated test formulation could be used as an effective 
complementary and alternative treatment and/or method of 
prevention for various types of autoimmune and inflammatory 
diseases, stress management and anti-aging as an effective 
anti-inflammatory and immunomodulatory product without 
any adverse effects. The Biofield Energy Treated test 
formulation can be a better complementary and alternative 
medicine to prevent the immune-mediated tissue damage in 
cases of organ transplants (for example kidney transplants, 
liver transplants and heart transplants), various autoimmune 
disorders such as Lupus, Addison Disease, Celiac Disease 
(gluten-sensitive enteropathy), Dermatomyositis, Graves’ 
Disease, Hashimoto Thyroiditis, Multiple Sclerosis (MS), 
Myasthenia Gravis, Pernicious Anemia, Aplastic Anemia, 
Reactive Arthritis, Rheumatoid Arthritis, Sjogren Syndrome, 
Systemic Lupus Erythematosus, Type 1 Diabetes, Alopecia 
Areata, Crohn’s Disease, Fibromyalgia, Vitiligo, Psoriasis, 
Scleroderma, Chronic Fatigue Syndrome and Vasculitis, as 
well as inflammatory disorders such as Asthma, Ulcerative 
Colitis, Alzheimer’s Disease, Atherosclerosis, Dermatitis, 
Diverticulitis, Hepatitis, Irritable Bowel Syndrome, and 
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Parkinson’s Disease etc. along with autoimmune and 
inflammatory diseases, stress management and anti-aging to 
improve overall health and quality of life. 
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